We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
MF
251
Magnetar Financial
Illinois
$26.5M -$50.5M -574,219 -66%
GLF
252
Groupe la Francaise
France
$25.9M +$26.1M +296,381 New
AB
253
Amalgamated Bank
New York
$25.9M -$596K -6,770 -2%
II
254
IFM Investors
Australia
$25.4M -$2.18M -24,762 -8%
ZDA
255
Zweig-DiMenna Associates
New York
$25.3M +$1.05M +11,900 +4%
PMAM
256
Picton Mahoney Asset Management
Ontario, Canada
$25.1M -$252K -2,858 -1%
Comerica Bank
257
Comerica Bank
Texas
$24.7M +$359K +4,074 +1%
CIS
258
Capital International Sarl
California
$24.6M +$12.7M +144,631 +111%
Man Group
259
Man Group
United Kingdom
$24.2M +$5.52M +62,662 +30%
BAMF
260
BI Asset Management Fondsmaeglerselskab
Denmark
$24.1M +$12.4M +141,398 +110%
BSA
261
Braun Stacey Associates
New York
$23.9M -$309K -3,513 -1%
IMPI
262
Ilmarinen Mutual Pension Insurance
Finland
$23.5M +$5.55M +63,000 +32%
EPFB
263
Employees Provident Fund Board
Malaysia
$23.3M +$23M +260,966 New
CPC
264
Cookson Peirce & Co
Pennsylvania
$23.1M +$160K +1,813 +0.7%
FAF
265
Fjarde Ap-fonden
Sweden
$22.8M -$1.65M -18,800 -7%
UIM
266
USS Investment Management
United Kingdom
$22.7M -$1.71M -19,427 -7%
TIAA Trust, National Association
267
TIAA Trust, National Association
North Carolina
$22.4M -$375K -4,263 -2%
URS
268
Utah Retirement Systems
Utah
$21.8M +$61.6K +700 +0.3%
EAM
269
Erste Asset Management
Austria
$21.7M -$1.69M -19,244 -7%
CIBC Asset Management
270
CIBC Asset Management
Ontario, Canada
$21.7M +$896K +10,181 +4%
RPI
271
Railway Pension Investments
United Kingdom
$21.6M
EI
272
Ethic Inc
New York
$21.6M +$4.13M +46,946 +24%
OSAM
273
O'Shaughnessy Asset Management
Connecticut
$21.4M +$2.08M +23,605 +11%
ZIM
274
Zacks Investment Management
Illinois
$21.4M -$1.43M -16,224 -6%
CWM
275
Congress Wealth Management
Massachusetts
$21M +$1.17M +13,293 +6%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.